Loading...
Therapies for acute myeloid leukemia: vosaroxin
Vosaroxin, a quinolone-derivative chemotherapeutic agent, was considered a promising drug for the treatment of acute myeloid leukemia (AML). Early-stage clinical trials with this agent led to a large randomized double-blind placebo-controlled study of vosaroxin in combination with intermediate-dose...
Na minha lista:
| Udgivet i: | Onco Targets Ther |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove Medical Press
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5558588/ https://ncbi.nlm.nih.gov/pubmed/28860803 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S121477 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|